Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1989-10-31
1992-04-28
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435968, 435975, 436 63, 436503, G01N 33567, G01N 3348
Patent
active
051088991
ABSTRACT:
The presence or amount of in vivo inflammation of a patient is determined by comparing the extent of opsonin receptor expression in vivo on phagocytes of a patient with the maximum opsonin receptor expression inducible on phagocytes of the patient in vitro after stimulation with a receptor expression priming agent. Preferably, the in vivo state of inflammation of a patient is determined by contacting a first portion of a phagocyte containing biological sample from the patient with a opsonified oxidative metabolism stimulating agent capable of elicting metabolic activation and with a chemiluminigenic substrate, contacting a second portion of the biological sample from the patient with an opsonin receptor expression priming agent, an opsonfield oxidative metabolism stimulating agent capable of eliciting metabolic activation and a chemiluminigenic substrate, and then comparing the chemiluminescence response of the first and second portions of the sample as a measure of the immune response potential or state of inflammation of the patient. Phagocyte function is additionally quantitatively evaluated by measuring the phagocyte oxygenation capacity of a maximally opsonin receptor primed and stimulated biological sample of a patient, determining the specific oxygenation capacity per phagocyte in the sample, and comparing the specific oxygenation capacity to a set of controls representing the normal distribution of specific oxygenation established from testing a large population. The phagocyte-specific oxygenation capacity is determined by contacting the sample with an opsonin receptor expression priming agent, an opsonified oxidative metabolism stimulating agent and a chemiluminigenic substrate, measuring the chemiluminescence response of the sample, determining the chemiluminescence response per phagocyte of the sample and comparing the response per phagocyte with that of the normal range of values. Kits and reagents are provided for use in the practice of the disclosed methods.
REFERENCES:
patent: 3689391 (1972-09-01), Ullman
patent: 3996345 (1976-12-01), Ullman et al.
patent: 3998943 (1976-12-01), Ullman
patent: 4104029 (1978-08-01), Maier, Jr.
patent: 4160645 (1979-07-01), Ullman
patent: 4161515 (1979-07-01), Ullman
patent: 4220450 (1980-09-01), Maggio
patent: 4231754 (1980-11-01), Vogelhut
patent: 4238195 (1980-12-01), Boguslaski et al.
patent: 4256834 (1981-03-01), Zuk et al.
patent: 4269938 (1981-05-01), Frank
patent: 4277437 (1981-07-01), Maggio
patent: 4302534 (1981-11-01), Halmann et al.
patent: 4372745 (1983-02-01), Mandle et al.
patent: 4380580 (1983-04-01), Boguslaski et al.
patent: 4383031 (1983-05-01), Boguslaski et al.
patent: 4436715 (1984-03-01), Schaap et al.
patent: 4478817 (1984-10-01), Campbell et al.
patent: 4521511 (1985-06-01), Stout
patent: 4598044 (1986-07-01), Kricka et al.
patent: 4729950 (1988-03-01), Kricka et al.
Van Dyke et al., Meth. Enzymology 133:493-507, 1986.
Fearon et al., J. Immunol. 130(1):370-375, 1983.
Allen, Meth. Enzymology 133:449-493, 1986.
Seitz, W. R., "Chemiluminescence Detection of Enzymically Generated Peroxide", Methods in Enzymology, LVII, 445-462, 1978.
Klebanoff, "Myeloperoxidase-Halide-Hydrogen Peroxide Antibacterial System," J. Bacteriol., 95, 2131-2138, 1968.
Allen, R. C., Dissertation entitled "Studies on the Generation of Electronic Excitation States in Human Polymorphonuclear Leukocytes and their Participation in Microbicidal Activity", Jul., 1973.
Allen, R. C. et al., "Evidence for the Generation of an Electronic Excitation State(s) in Human Polymorphonuclear Leukocytes and its Participation in Bactericidal Activity", Biochemical and Biophysical Research Communications, 47(4), 679-684, 1972.
Allen, R. C., "Halide Dependence of the Myeloperoxidase-Mediated Antimicrobial System of the Polymorphonuclear Leukocyte in the Phenomenon of Electric Excitation", Biochemical and Biophysical Research Communications, 63(3), 675-683, 1975.
Allen, R. C., "The Role of pH in the Chemiluminescent Response of the Myeloperoxidase-Halide-HOOH Antimicrobial System", Biochemical and Biophysical Research Communications, 63(3), 684-691, 1975.
Allen, R. C. and L. D. Loose, "Phagocytic Activation of a Luminol-Dependent Chemiluminescence in Rabbit Alveolar and Peritoneal Macrophages", Biochemical and Biophysical Research Communications, 69(1), 245-252, 1976.
Allen, R. C., "Evaluation of Serun Opsonic Capacity by Quantitating the Initial Chemiluninescent Response from Phagocytizing Polymorphonuclear Leukocytes", Infection and Immunity, 15(3), 828-833, 1977.
Allen, R. C. et al., "Correlation of Metabolic and Chemiluminescent Responses of Granulocytes from Three Female Siblings with Chronic Granulomatous Disease", Journal of Infectious Diseases, 136(4), 510-518, 1977.
Allen, R. C., "Reduced Radical, and Excited State Oxygen in Leukocyte Microbicidal Activity", In J. T. Dingle, P. J. Jacques and J. H. Shaw [eds.] Lysosomes in Applied Biology and Therapeutics, North-Holland Publishing Company, 1979, pp. 197-233.
Allen, R. C., "Chemiluminescence: An Approach to the Study of the Humoral-Phagocyte Axis in Host Defense Against Infection", In Liquid Scintillation Counting, Recent Applications and Development, vol. II. Sample Preparation and Applications, Academic Press, Inc., 1980, pp. 377-393.
Allen, R. C. et al., "Role of Myeloperoxidase and Bacterial Metabolism in Chemiluminescence of Granulocytes from Patients with Chronic Granulomatous Disease", Journal of Infectious Disease, 144(4), 344-348, 1981.
Allen, R. C. et al., "Humoral-Phagocyte Axis of Immune Defense in Burn Patients", Archives of Surgery, 117, 133-140, 1982.
Allen, R. C., "Direct Quantification of Phagocyte Activity in Whole Blood: A Chemiluminigenic Probe Approach", In E. Kaiser, F. Gabl, M. M. Muller and P. M. Bayer [eds.] Proceedings of XI International Congress of Clinical Chemistry, Vienna, 1981. Walter de Gruyter, Berlin, New York, 1982, pp. 1043-1058.
Allen, R. C., "Biochemiexcitation: Chemiluminescence and the Study of Biological Oxygenation Reactions", In W. Adam and G. Cilento [eds.] Chemical and Biological Generation of Excited States, Acadamic Press, Inc., New York, 1982, pp. 309-344.
Allen, R. C., "Chemiluminescence and the Study of Phagocyte Redox Metabolism", In F. Rossi and P. Patrisica [eds.] Biochemistry and Function of Phagocytes, Plenum Publishing Corporation, 1982, pp. 411-421.
Allen, R. C. and M. M. Lieberman, "Kinetic Analysis of Microbe Opsonification Based on Stimulated Polymorphonuclear Leukocyte Oxygenation Activity", Infection and Immunity 45(2), 475-482, 1984.
Allen, R. C. "Phagocytic Leukocyte Oxygenation Activities and Chemiluminescence: A Kinetic Approach to Analysis", In Marlene A. DeLuca and William D. McElroy [eds.] Methods in Enzymology, vol. 133, Bioluminescence and Chemiluminescence, Academic PRess, Inc., 1986, pp. 449-493.
Allen, R. C., "Oxygen-Dependent Microbe Killing by Phagocyte Leukocytes: Spin Conservation and Reaction Rate", In W. Ando and Y. Moro-oka [eds.] The Role of Oxygen in Chemistry and Biochemistry, Proceedings of an International Symposium on Activation of Dioxygen and Homogeneous Catalytic Oxidations, Tsukuba, Japan, 12-16 Jul. 1987, Studies in Organic Chemistry, vol. 33, pp. 425-434, 1988 Elsevier Science Publishers B. V. Amsterdam.
Steinbeck, M. J. and J. A. Roth, "Neutrophil Activation by Recombinant Cytokines", Reviews of Infectious Diseases, 11(4), 549-568, 1989.
Malech, H. L. and J. I. Gallin, "Medical Intelligence, Neutrophils in Human Diseases", New England Journal of Medicine, 317(11), 687-694, 1987.
Olsson, I. and P. Venge, "The Role of the Human Neutrophil in the Inflammatory Reaction", Allergy, 35, 1-13, 1980.
Cooper, N. R., "Assays for Complement Activation", In Robert M. Nakamura and David T. Rowlands [eds.] Clinics in Laboratory Medicine, Advances in Immunopathology, vol. 6, No. 1, pp. 139-155, Mar. 1986, W. B. Saunders Co.
Chenoweth, D. E., "Complement Mediators of Inflammation", In Gordon D. Ross [ed.] Immunobiology of the Complement System, An Introduction for Research and Clinical Medicine, pp. 63-86, Academic Press, 19
ExOxEmis, Inc.
Kepplinger Esther L.
Wortman Donna C.
LandOfFree
Chemiluminescence assay of in vivo inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemiluminescence assay of in vivo inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemiluminescence assay of in vivo inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248797